| Dr Kahdi F Udobi, MD | |
|
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3031 | |
| (404) 616-1415 | |
| (404) 616-1417 |
| Full Name | Dr Kahdi F Udobi |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 44 Years |
| Location | 80 Jesse Hill Jr Dr Se, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205935624 | NPI | - | NPPES |
| 25911010 | Other | MO | BCBS KANSAS CITY |
| 372600 | Other | KS | FIRSTGUARD |
| 100345850A | Medicaid | KS | |
| 204755102 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 04-28402 (Kansas) | Secondary |
| 2086S0102X | Surgery - Surgical Critical Care | 078646 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Highland Dubois | Dubois, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dubois Regional Medical Center | 5890689715 | 349 |
News Archive
Cancer is relentless and resilient. When a drug blocks a cancer cell's main survival pathway, the cell avoids the obstacle by taking different pathways or detours to save itself. This tactic is called "developing resistance," and it's one of the key challenges researchers face when seeking effective therapeutics to combat pancreatic ductal adenocarcinoma (PDA).
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy. The finding means that nearly all patients in need of a transplant can find donors, according to Johns Hopkins scientists who participated in the trials.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base).
› Verified 2 days ago
| Entity Name | Dubois Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508046814 PECOS PAC ID: 5890689715 Enrollment ID: O20050328000673 |
News Archive
Cancer is relentless and resilient. When a drug blocks a cancer cell's main survival pathway, the cell avoids the obstacle by taking different pathways or detours to save itself. This tactic is called "developing resistance," and it's one of the key challenges researchers face when seeking effective therapeutics to combat pancreatic ductal adenocarcinoma (PDA).
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy. The finding means that nearly all patients in need of a transplant can find donors, according to Johns Hopkins scientists who participated in the trials.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kahdi F Udobi, MD 720 Westview Dr Sw, Atlanta, GA 30310-1458 Ph: (404) 616-1415 | Dr Kahdi F Udobi, MD 80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3031 Ph: (404) 616-1415 |
News Archive
Cancer is relentless and resilient. When a drug blocks a cancer cell's main survival pathway, the cell avoids the obstacle by taking different pathways or detours to save itself. This tactic is called "developing resistance," and it's one of the key challenges researchers face when seeking effective therapeutics to combat pancreatic ductal adenocarcinoma (PDA).
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy. The finding means that nearly all patients in need of a transplant can find donors, according to Johns Hopkins scientists who participated in the trials.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base).
› Verified 2 days ago
Dr. Dominic Joseph Papandria, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 Peachtree St Ne, Atlanta, GA 30308 Phone: 404-686-4411 | |
John Sweeney, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1365a Clifton Rd Ne, Suite 3300, Atlanta, GA 30322 Phone: 404-778-3712 Fax: 404-778-5033 | |
Marlieke E Nussenbaum, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 1015 Boulevard Se Apt 629, Atlanta, GA 30312 Phone: 919-360-5327 | |
Samantha Courtney Thomas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 69 Jesse Hill Jr Drive, Glenn Memorial Building, 3rd Floor, Atlanta, GA 30303 Phone: 404-251-8915 Fax: 404-523-3931 | |
Vanessa Arientyl, MD Surgery Medicare: Medicare Enrolled Practice Location: 69 Jesse Hill Jr. Drive Southeast, Glenn Memorial Building, 3rd Floor, Atlanta, GA 30303 Phone: 404-251-8915 Fax: 404-523-3931 | |
Mr. Barrie Douglas Lowman, P.A. Surgery Medicare: Medicare Enrolled Practice Location: 5669 Peachtree Dunwoody Rd Ne, Suite 100, Atlanta, GA 30342 Phone: 404-256-0404 Fax: 404-847-0423 | |
Dr. Eric T Elwood, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 80 Gilmer St Se, Atlanta, GA 30303 Phone: 404-616-1000 |